Shares of Arena Pharmaceuticals (ARNA -7.2%) continue Friday's downward trajectory after minutes...

|About: Arena Pharmaceuticals, Inc. (ARNA)|By:, SA News Editor

Shares of Arena Pharmaceuticals (ARNA -7.2%) continue Friday's downward trajectory after minutes from the May 10th FDA panel on the company's obesity drug lorcaserin were posted, and don't show the in a favorable light. Many panelists appear to have voted yes, but only reluctantly.